Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
- 1 June 2001
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (6) , 430-439
- https://doi.org/10.1038/sj.cgt.7700323
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of CancerHuman Gene Therapy, 1994
- p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 1994
- Epstein-Barr virus strategy in normal and neoplastic B cellsCell, 1994
- The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesisBritish Journal of Cancer, 1994
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- p53 is frequently mutated in Burkitt's lymphoma cell lines.The EMBO Journal, 1991
- p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.Proceedings of the National Academy of Sciences, 1991
- The p53 tumour suppressor geneNature, 1991
- Genetic Mechanisms of Tumor Suppression by the Human p53 GeneScience, 1990